Tailored antiplatelet therapy in high-risk ACS patients treated with PCI stenting: lessons from the ANTARCTIC trial
J Thorac Dis
.
2017 May;9(5):E440-E443.
doi: 10.21037/jtd.2017.04.46.
Authors
Nathan Messas
1
,
Jean-François Tanguay
1
2
,
Marie Lordkipanidzé
3
4
Affiliations
1
Department of Medicine, Montreal Heart Institute, Montreal, Québec, Canada.
2
Faculté de médecine, Université de Montréal, Montréal, Québec, Canada.
3
Faculté de pharmacie, Université de Montréal, Montréal, Québec, Canada.
4
Research center, Montreal Heart Institute, Montréal, Québec, Canada.
PMID:
28616304
PMCID:
PMC5465104
DOI:
10.21037/jtd.2017.04.46
No abstract available
Publication types
Editorial
Comment